Loading Events

« All Events

  • This event has passed.

Drug safety surveillance with third parties

October 5, 2021 @ 11:00 am - 12:00 pm EDT

Free
Baker Tilly CPE Webinars

Participants of the live webinar will be eligible for 1 free CPE credit.

Register

Additional layers of complexity and uncertainty continue to be added to how life sciences companies bring their products to market as more stakeholders become involved in the commercialization process. While much emphasis is placed on company compliance with regulatory requirements – less emphasis has been placed on vendors or global commercial partners. By not having an established auditing, monitoring and surveillance program of third parties, an undue amount of risk and uncertainty can be imposed on drug manufacturers and their products.

Join us for an informative presentation about drug safety governance when working with third parties. Our colleagues will discuss:

  • The components of an effective governance policy
  • The importance of having established communication channels between companies and third parties, even when stakeholder software and systems are not fully integrated
  • How to protect the value of your drug or product by managing your company’s global responsibly through vendor relationships

Who should attend?

  • C-Suite, legal, regulatory affairs, medical affairs, quality and safety, internal audit, and compliance and monitoring professionals at emerging and established life sciences companies

Presenters

  • Darren Jones, CIA, Principal and Life Sciences Consulting Practice Leader, Baker Tilly
  • Ashley Jones, JD, Legal Consultant, Baker Tilly
  • Jamie Portnoff, Principal Consultant/Owner, JMP Consulting

Learning objectives

  • Know the components of an effective governance policy
  • Identify the importance of having established communication channels between companies and third parties, even when stakeholder software and systems are not fully integrated
  • Understand how to protect the value of your drug or product by managing your company’s global responsibly through vendor relationships

Information about CPE eligibility

There are no prerequisites for this webinar, and advance preparation is not required. There is no cost to attend this webinar.

Level: Overview

CPE credit: One (1) hour total credit

Field of study: Management Advisory Services

A certificate of completion will be emailed to you four to six weeks after the event.

For more information regarding administrative policies such as complaint and refund, please contact our offices at +1 (608) 240 2522.

NASBA logo

Baker Tilly US, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: learningmarket.org.

2 Responses to “Drug safety surveillance with third parties”

  1. do I need to register for this or if I add to my calendar will I get the link

  2. You need to register.

Leave a Reply

Subscribe Here